GLYXAMBI Drug Profile, 2020

$499.00

GLYXAMBI Drug Profile, 2020

This report focuses on GLYXAMBI and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Drug prices
  • Finished product suppliers
SKU: 206073 Category:

Description

Copyright © DrugPatentWatch. Originally published at GLYXAMBI Drug Profile, 2020

GLYXAMBI Drug Profile, 2020

This report focuses on GLYXAMBI and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Drug prices
  • Finished product suppliers

Contents

  • Profile for GLYXAMBI
  • US Patents
  • US Regulatory Exclusivity
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • US Patent Trial and Appeal Board Cases
  • International (exUS) Patents
  • Supplementary Protection Certificates
  • Drug Prices – Average Pharmacy Cost
  • Drug Prices – Best Wholesale Price
  • Finished Product Suppliers

    Make Better Decisions with DrugPatentWatch

    Get the Daily Briefing or Try a trial

    Copyright © DrugPatentWatch. Originally published at GLYXAMBI Drug Profile, 2020